Clinical Conditions and Predictive Markers of Non-Dipper Profile in Hypertensive Patients

1. Mills KT, Bundy JD, Kelly TN, et al – Global disparities of hypertension prevalence and control a systematic analysis of population - based studies from 90 countries. Circulation. 2016;134(6):441-450.10.1161/CIRCULATIONAHA.115.018912Search in Google Scholar

2. Lloyd-Sherlock P, Beard J, Minicuci N, Ebrahim S, Chatterji S – Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control. International Journal of Epidemiology, 2014;43(1):116-128.10.1093/ije/dyt215Open DOISearch in Google Scholar

3. Dorobantu M, Onciul S, Darabont R, et al – Arterial Hypertension Epidemiology: Romania among the Balkan Countries – Data from SEPHAR Surveys. Medicina Moderna. 2014;21(1):10-16.Search in Google Scholar

4. Dorobantu M, Tautu OF, Dimulescu D, et al – Perspectives on hypertension's prevalence, treatment and control in a high cardiovascular risk East European country: data from the SEPHAR III survey. J Hypertens. 2017. doi:10.1097/HJH.0000000000001572. [Epub ahead of print]10.1097/HJH.0000000000001572.[EpubaheadprintOpen DOISearch in Google Scholar

5. Hermida RC, Smolensky MH, Ayala DE, Portaluppi F – Ambulatory blood pressure monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults. Chronobiol Int. 2015;32(10):1329–1342.10.3109/07420528.2015.1113804Search in Google Scholar

6. Mancia G, Fagard R, Narkiewicz K, et al – 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013;31:1281–1357.10.1097/01.hjh.0000431740.32696.ccSearch in Google Scholar

7. Routledge FS, McFetridge-Durdle JA, Dean CR – Night-time blood pressure patterns and target organ damage: A review. Can J Cardiol. 2007;23(2):132-138.10.1016/S0828-282X(07)70733-XOpen DOISearch in Google Scholar

8. Krzych LJ, Bochenek A – Blood pressure variability: epidemiological and clinical issues. Cardiol J. 2013;20(2):112–120.10.5603/CJ.2013.0022Search in Google Scholar

9. Birkenhäger AM, van den Meiracker AH. – Causes and consequences of a non-dipping blood pressure profile. Neth J Med. 2007;65(4):127-131.Search in Google Scholar

10. Dubielski Z, Zamojski M, Wiechecki B, et al. – The current state of knowledge about the dipping and non-dipping hypertension. Arterial Hypertension. 2016; 20(2):33–43.10.5603/AH.2016.0007Search in Google Scholar

11. Letizia C, Ferrari P, Cotesta D, et al. Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism. J Hum Hypertens 2005;19(11):901-916.10.1038/sj.jhh.100190716034450Search in Google Scholar

12. Krzyzanowska K, Schnack C, Mittermayer F, et al – High prevalence of abnormal circadian blood pressure regulation and impaired glucose tolerance in adults with hypopituitarism. Exp Clin Endocrinol Diabetes. 2005;113(8):430-434.10.1055/s-2005-86577216151976Search in Google Scholar

13. Pechanova O, Paulis L, Simko F – Peripheral and central effects of melatonin on blood pressure regulation. Int J Mol Sci 2014;15(10):17920–17937.10.3390/ijms151017920422719725299692Search in Google Scholar

14. Pietrobelli DJ, Akopian M, Olivieri AO, et al – Altered circadian blood pressure profile in patients with active acromegaly. Relationship with left ventricular mass and hormonal values. J Hum Hypertens. 2001;15(9):601-605.10.1038/sj.jhh.100123911550105Open DOISearch in Google Scholar

15. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, et al – What added value does ambulatory blood pressure monitoring brings to the management of post renal transplantation hypertension? Rev Med Chir Soc Med Nat Iasi 2003;107(1):89-97.Search in Google Scholar

16. Ohashi N, Isobe S, Ishigaki S, Suzuki T, Motoyama D, Sugiyama T, et al – The effects of unilateral nephrectomy on blood pressure and its circadian rhythm. Intern Med. 2016;55(23):3427–3433.10.2169/internalmedicine.55.7215521613827904104Search in Google Scholar

17. Kario K, Eguchi K, Nakagawa Y, Motai K, Shimada K – Relationship between extreme dippers and orthostatic hypertension in elderly hypertensive patients. Hypertension. 1998;31(1):77-82.10.1161/01.HYP.31.1.779449395Open DOISearch in Google Scholar

18. Briasoulis A, Silver A, Yano Y, Bakris GL – Orthostatic hypotension associated with baroreceptor dysfunction: treatment approaches. J Clin Hypertens (Greenwich). 2014;16:141–148.10.1111/jch.12258803186824588814Open DOISearch in Google Scholar

19. Mellman TA, Brown DD, Jenifer ES, Hipolito MM, Randall OS – Posttraumatic stress disorder and nocturnal blood pressure dipping in young adult African Americans. Psychosom Med. 2009;71(6): 627–630.10.1097/PSY.0b013e3181a5434119483123Search in Google Scholar

20. Huang Y, Mai W, Hu Y, et al – Poor sleep quality, stress status, and sympathetic nervous system activation in nondipping hypertension. Blood Press Monit. 2011;16(3):117–123.10.1097/MBP.0b013e328346a8b421562453Open DOISearch in Google Scholar

21. Xuan AP – Investigate damages in target organs in two groups of patients who have dipper and non-dipper hypertension. J Hypertens. 2011;29:e11.10.1097/01.hjh.0000408011.10529.0dSearch in Google Scholar

22. Nesukay H, Polenova N, Titov E – Ambulatory blood pressure monitoring (ABPM) and myocardium deformation parameters in patients with hypertension. J Hypertens. 2016;34:e122-e123.10.1097/01.hjh.0000491659.27451.e1Search in Google Scholar

23. Sousa F, Neves J, Ferreira R, et al. – In hypertension the change from a non-dipper to a dipper pattern is associated with a better cardiovascular prognosis than the persistence within the non-dipper pattern. J Hypertens. 2015;33(1):e6.10.1097/01.hjh.0000467367.65699.19Search in Google Scholar

24. Crippa G, Zabzuni D, Cassi A, Bravi E – Effect of bedtime dosing of barnidipine hydrochloride in non-dipper hypertensive patients with obstructive sleep apnoea not treated with continuous positive airway pressure. Eur Rev Med Pharmacol Sci. 2016;20(2):339-344.Search in Google Scholar

25. Kario K, Nariyama J, Kido H, et al – Effect of a novel calcium channel blocker on abnormal nocturnal blood pressure in hypertensive patients. J Clin Hypertens (Greenwich). 2013;15(7):465-472.10.1111/jch.12113803397123815534Open DOISearch in Google Scholar

26. Esler M. The sympathetic system and hypertension. Am J Hypertens. 2000;13:99S–105S.10.1016/S0895-7061(00)00225-9Open DOISearch in Google Scholar

27. Dauphinot V, Gosse P, Kossovsky M, et al – Autonomic nervous system activity is independently associated with the risk of shift in the non-dipper blood pressure pattern. Hypertens Res. 2010;33:1032–1037.10.1038/hr.2010.130Open DOISearch in Google Scholar

28. Quijada SG, Sáez MC, Gutiérrez CD, et al – Factores cardiovasculares y hormonales asociados a la falta de descenso nocturno de la presión arterial en sujetos mayores de 55 años. Rev Clin Esp. 2002;202(5):264-268.10.1016/S0014-2565(02)71048-5Search in Google Scholar

29. Grassi G, Seravalle G, Quarti-Trevano F, et al – Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension. 2008;52:925-931.10.1161/HYPERTENSIONAHA.108.11636818779438Open DOISearch in Google Scholar

30. Voichanski S, Grossman C, Leibowitz A, et al – Orthostatic hypotension is associated with nocturnal change in systolic blood pressure. Am J Hypertens. 2012;25(2):159-164.10.1038/ajh.2011.19122012209Open DOISearch in Google Scholar

31. Alquadan KF, Singhania G, Koratala A, Eja AA – Office orthostatic blood pressure measurements and ambulatory blood pressure monitoring in the prediction of autonomic dysfunction. Clin Hypertens. 2017;23:3.10.1186/s40885-016-0059-4535124928331633Search in Google Scholar

32. Hossain P, Kawar B, El Nahas M – Obesity and diabetes in the developing world – a growing challenge. N Engl J Med 2007;356(3):213–215.10.1056/NEJMp06817717229948Search in Google Scholar

33. Faulkner JL, Bruder-Nascimento T, Belin de Chantemèle EJ – The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease. Curr Opin Nephrol Hypertens. 2017;doi:10.1097/MNH.0000000000000384. [Epub ahead of print]10.1097/MNH.0000000000000384.[EpubaheadprintOpen DOISearch in Google Scholar

34. Ruano M, Silvestre V, Castro R, et al – Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis. Obes Surg 2005;15:670–676.10.1381/0960892053923734Open DOISearch in Google Scholar

35. Westcott KV, Huang BS, Leenen FH – Brain renin-angiotensin-aldosterone system and ventricular remodelling after myocardial infarct: a review. Can J Physiol Pharmacol. 2009;87:979–988.10.1139/Y09-067Search in Google Scholar

36. Stepniakowski KT, Goodfriend TL, Egan BM – Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension. 1995;25:774–778.10.1161/01.HYP.25.4.774Open DOISearch in Google Scholar

37. de Courten M, Zimmet P, Hodge A. et al – Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med. 1997;14:200–208.10.1002/(SICI)1096-9136(199703)14:3<200::AID-DIA336>3.0.CO;2-VSearch in Google Scholar

38. Kang YS – Obesity associated hypertension: new insights into mechanism. Electrolyte Blood Press. 2013;11:46–52.10.5049/EBP.2013.11.2.46395022524627704Search in Google Scholar

39. Kanbay M, Turgut F, Uyar ME, et al – Causes and mechanisms of nondipping hypertension. Clin Exp Hypertens. 2008;30:585–597.10.1080/1064196080225197418855262Open DOISearch in Google Scholar

40. Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi F – Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol Int. 2013;30(1-2):17–3010.3109/07420528.2012.71587223002916Open DOISearch in Google Scholar

41. Ayukusuma AR, Rohman MS, Lukitasari M et al – No difference of serum IL-6 level among dipper and non dipper hypertensive patients. J Hypertens. 2015; doi: 10.1097/01.hjh.0000469858.46811.f410.1097/01.hjh.0000469858.46811.f4Open DOISearch in Google Scholar

42. Duggal A, Bal BS, Singh N – Study of dipping and non-dipping patterns in patients of type 2 diabetes mellitus with hypertension and its association with microalbuminuria. Ann Int Med Den Res. 2017;3(2):20-24.10.21276/aimdr.2017.3.2.ME6Search in Google Scholar

43. Tartan Z, Uyarel H, Kasikcioglu H, et al – Metabolic syndrome as a predictor of non-dipping hypertension. Tohoku J Exp Med. 2006;210:57–66.10.1620/tjem.210.5716960346Search in Google Scholar

44. Tutal E, Sayın B, Ertugrul DT, et al – Is there a link between hyperuricemia, morning blood pressure surge, and non-dipping blood pressure pattern in metabolic syndrome patients? Int J Nephrol Renovasc Dis. 2013;6:71–77.10.2147/IJNRD.S41384364736023662072Search in Google Scholar

45. Karaagac K, Tenekecioglu E, Yontar OC, et al – Effect of non-dipper and dipper blood pressure patterns on Tp-Te interval and Tp-Te/QT ratio in patients with metabolic syndrome. Int J Clin Exp Med. 2014;7(5):1397-1403.Search in Google Scholar

46. Karaagac K, Vatansever F, Tenekecioglu E, et al – The relationship between non-dipper blood pressure and thoracic aortic diameter in metabolic syndrome. Eurasian J Med. 2014;46:120-125.10.5152/eajm.2014.27426145625610310Search in Google Scholar

47. Ma Y, Sun S, Peng CK, Fang Y, Thomas RJ – Ambulatory blood pressure monitoring in chinese patients with obstructive sleep apnea. J Clin Sleep Med. 2017;13(3):433–439.10.5664/jcsm.6498533759127855748Open DOISearch in Google Scholar

48. Suzuki M, Guilleminault C, Otsuka K, Shiomi T – Blood pressure “dipping” and “non-dipping” in obstructive sleep apnea syndrome patients. Sleep. 1996;19(5):382–38710.1093/sleep/19.5.3828843529Open DOISearch in Google Scholar

49. Nabe B, Lies A, Pankow W, Kohl FV, Lohmann FW – Determinants of circadian blood pressure rhythm and blood pressure variability in obstructive sleep apnoea. J Sleep Res. 1995;4(S1):97–10110.1111/j.1365-2869.1995.tb00196.xSearch in Google Scholar

50. Wolf J, Hering D, Narkiewicz K – Non-dipping pattern of hypertension and obstructive sleep apnea syndrome. Hypertens Res. 2010;33(9):867–871.10.1038/hr.2010.153Open DOISearch in Google Scholar

51. de Paula Soares CF, Cavichio L, Cahali MB – Lateral pharyngoplasty reduces nocturnal blood pressure in patients with obstructive sleep apnea. Laryngoscope. 2014;124:311–316.10.1002/lary.24312Search in Google Scholar

52. Routledge FS, McFetridge-Durdle JA, Dean CR – Stress, menopausal status and nocturnal blood pressure dipping patterns among hypertensive women. Can J Cardiol. 2009;25(6):e157-e163.10.1016/S0828-282X(09)70089-3Open DOISearch in Google Scholar

53. Refaie WR, Refaie E, Abd El Hady N, et al – Cardiovascular changes in dipper and nondipper hypertension in perimenopausal women (time-dependent effects of antihypertensives). Egypt J Int Med. 2012;24(2):37-42.Search in Google Scholar

54. Iqbal A, Figenschau Y, Jorde R – Blood pressure in relation to serum thyrotropin: The Tromsø study. J Hum Hypertens. 2006;20:932–93610.1038/sj.jhh.100209117024137Open DOISearch in Google Scholar

55. Canbolat IP, Belen E, Bayyigit A, et al – Evaluation of Daily Blood Pressure Alteration in Subclinical Hypothyroidism. Acta Cardiol Sin. 2017;33(5): 489–494.Search in Google Scholar

56. Kanbay M, Turgut F, Karakurt F, et al – Relation between serum thyroid hormone and ‘nondipper’ circadian blood pressure variability. Kidney Blood Press Res. 2007; 30(6): 416–420.10.1159/00011008217960070Search in Google Scholar

57. Kanbay M, Isik B, Akcay A et al – Relation between serum calcium, phosphate, parathyroid hormone and ‘nondipper’ circadian blood pressure variability profile in patients with normal renal function. Am J Nephrol. 2007;27(5):516–521.10.1159/00010748917703091Open DOISearch in Google Scholar

58. Velasquez MT, Beddhu S, Nobakht E, Rahman M, Raj DS – Ambulatory blood pressure in chronic kidney disease: ready for prime time? Kidney Int Rep. 2016;1(2):94–104.10.1016/j.ekir.2016.05.001528380028164170Search in Google Scholar

59. Fedecostante M, Spannella F, Cola G, et al – Chronic kidney disease is characterized by “double trouble” higher pulse pressure plus night-time systolic blood pressure and more severe cardiac damage. PLoS One 2014;9(1):e86155.10.1371/journal.pone.0086155390049024465931Search in Google Scholar

60. Lurbe E, Redon J, Kesani A, et al – Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347(11):797–805.10.1056/NEJMoa01341012226150Search in Google Scholar

61. Sezer S, Karakan S, Çolak T, Haberal M – Nocturnal nondipping hypertension is related to dyslipidemia and increased renal resistivity index in renal transplant patients. Transplant Proc. 2011;43(2):530–532.10.1016/j.transproceed.2011.01.01321440752Search in Google Scholar

62. Wadei HM, Amer H, Griffin MD, Taler SJ, Stegall MD, Textor SC. Abnormal circadian blood pressure pattern 1-year after kidney transplantation is associated with subsequent lower glomerular filtration rate in recipients without rejection. J Am Soc Hypertens. 2011;5(1):39-47.10.1016/j.jash.2010.11.00421269908Search in Google Scholar

63. Choudhary L, Gupta P, Gupta A, et al – 24 hour ambulatory blood pressure monitoring and left ventricular ejection fraction-prognostic markers in chronic kidney disease. Int J Adv Med. 2016;3(2):402-408.10.18203/2349-3933.ijam20161100Open DOISearch in Google Scholar

64. Dziwura J, Bińczak-Kuleta A, Miazgowski T, et al – The associations between G972R polymorphism of the IRS-1 gene, insulin resistance, salt sensitivity and non-dipper hypertension. Hypertens Res. 2011;34:1082–1086.10.1038/hr.2011.8021677657Search in Google Scholar

65. Uzu T, Ishikawa K, Fujii T, et al. – Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation, 1997;96:1859–1862.10.1161/01.CIR.96.6.1859Search in Google Scholar

66. Campese VM, Romoff MS, Levitan D, et al. – Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int. 1982;21:371–378.10.1038/ki.1982.327069999Open DOISearch in Google Scholar

67. Piepoli MF, Hoes AW, Agewall S, et al – 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37:2315-2381.10.1093/eurheartj/ehw106Search in Google Scholar

68. Chen Y, Liu JH, Zhen Z, et al. – Assessment of left ventricular function and peripheral vascular arterial stiffness in patients with dipper and non-dipper hypertension. J Investig Med. 2017; pii: jim-2017-00051310.1136/jim-2017-000513580035428935634Search in Google Scholar

69. Mahabala C, Kamath P, Bhaskaran U, et al – Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently? Vasc Health Risk Manag. 2013;9:125–133.10.2147/VHRM.S33515Search in Google Scholar

70. Kario K, Schwartz JE, Pickering TG - Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of alpha-adrenergic blocker, doxazosin: results from the HALT study. Hypertension. 2000;35(3):787-794.10.1161/01.HYP.35.3.787Open DOISearch in Google Scholar

71. Wang C, Ye Y, Liu C, et al – Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis. Intern Med J. 2017;47(8):900-906.10.1111/imj.1349028544243Search in Google Scholar

72. Wang C, Zhang J, Liu X, et al – Effect of Valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern. J Clin Hypertens (Greenwich). 2013;15(1):48-54.10.1111/jch.12021810826323282124Open DOISearch in Google Scholar

73. Fukuda M, Kimura G. Salt sensitivity and nondippers in chronic kidney disease. Curr Hypertens Rep. 2012;14(5):382-387.10.1007/s11906-012-0286-322898905Open DOISearch in Google Scholar

74. Tosu AR, Demir S, Selcuk M, et al – Comparison of inflammatory markers in non-dipper hypertension vs. dipper hypertension and in normotensive individuals: uric acid, C-reactive protein and red blood cell distribution width readings. Postepy Kardiologii Interwencyjnej. 2014;10(2):98–103.10.5114/pwki.2014.43514Search in Google Scholar

75. Buyukkaya E, Erayman A, Karakas E, et al – Relation of red cell distribution width with dipper and non-dipper hypertension. Medicinski Glasnik. 2016;13(2):75-81.Search in Google Scholar

76. Kaya MG, Yarlioglues M, Gunebakmaz O, et al. – Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis. 2010;209(1):278-282.10.1016/j.atherosclerosis.2009.09.01019782364Search in Google Scholar

77. Ortakoyluoglu A, Boz B, Sitki DO, et al – The association of serum gamma-glutamyl transpeptidase level and other laboratory parameters with blood pressure in hypertensive patients under ambulatory blood pressure monitoring. Ther Clin Risk Manag. 2016;12:1395-1401.10.2147/TCRM.S116603501946827660457Search in Google Scholar

78. Tabara Y, Igaseb M, Mikia T, et al – B-type natriuretic peptide is a determinant of the nocturnal increase in blood pressure independently of arterial hypertrophy and hypoxia. J Hypertens. 2016;34:2393-2401.10.1097/HJH.000000000000110427753705Open DOISearch in Google Scholar

79. Bakirci EM, Degirmenci H, Hamur H, et al. – New inflammatory markers for prediction of non-dipper blood pressure pattern in patients with essential hypertension: Serum YKL-40/Chitinase 3-like protein 1 levels and echocardiographic epicardial adipose tissue thickness. Clin Exp Hypertens. 2015;37:1–6.10.3109/10641963.2015.101312225919569Search in Google Scholar

80. Ji Q, Cheng G, Ma N, et al – Circulating Th1, Th2, and Th17 levels in hypertensive patients. Dis Markers. 2017; 714629010.1155/2017/7146290551671528757677Search in Google Scholar

81. Kadoya M, Koyama H, Kanzaki A, et al – Plasma brain-derived neurotrophic factor and reverse dipping pattern of nocturnal blood pressure in patients with cardiovascular risk factors. PLoS One. 2014;9(8): e105977.10.1371/journal.pone.0105977414331625153796Search in Google Scholar

82. Meric M, Soylu K, Avci B, et al – Evaluation of plasma chemerin levels in patients with non-dipper blood pressure patterns. Med Sci Monit. 2014;20:698–705.10.12659/MSM.890784401060024769499Search in Google Scholar

83. Zheng H, Xie X, Xie N, Xu H, et al – Sphingomyelin levels in nondipper and dipper hypertensive patients. Exp Ther Med. 2014;7:599-603.10.3892/etm.2013.1455391989924520252Open DOISearch in Google Scholar

84. Cayli M, Gur M, Elbasan Z, et al – High-Sensitivity Cardiac Troponin T Predicts Nondipper Hypertension in Newly Diagnosed Hypertensive Patients. J Clin Hypertens (Greenwich). 2013;15(10):731-736.10.1111/jch.12176803387324088281Search in Google Scholar